“What makes drug development long and expensive is the need to prove, beyond statistical doubt, that your damn drug works” Michael Gilman, Biotech Entrepreneur 2017 is going to be terrific. Tremendous, even. Things are going to change, big league. The … Continue reading
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.